Mind Medicine (MindMed) Inc.
MNMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.07 | -0.04 | 0.16 | -0.03 |
| FCF Yield | -2.92% | -5.34% | -5.91% | -4.34% |
| EV / EBITDA | -15.04 | -13.90 | -19.20 | -9.75 |
| Quality | ||||
| ROIC | -26.63% | -18.01% | -13.13% | -12.33% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.44 | 0.69 | 1.26 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.11% | -0.61% | -16.05% | -47.47% |
| Safety | ||||
| Net Debt / EBITDA | 0.30 | -0.19 | 2.67 | 7.39 |
| Interest Coverage | -35.85 | -17.49 | -53.42 | -49.48 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |